Product Information

AMITRIPTYLINE HCL 150 MG TAB is a generic product labeled by Advagen Pharma Ltd., priced at $0.2841 per EA under NDC 72888007201. Its NADAC has been published 89 times since Mar 12, 2025.

FDA first approved this application on May 1, 2023. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

AMITRIPTYLINE HCL 150 MG TAB

Amitriptyline Hydrochloride
$0.2841per EA

Strength

150 mg/1

NDC

72888007201

Classification

Generic

Dosage Form

TABLET, FILM COATED

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

AMITRIPTYLINE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA215376

FDA Approved

5/1/2023

TE Code

AB

On Market Since

5/1/2023

Pharmacological Classes

Price Statistics

The NADAC for AMITRIPTYLINE HCL 150 MG TAB has been published 89 times since Mar 12, 2025, and over the history we have for it it has risen 53.5%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2841 per EA
All-time high$0.3070 (Sep 16, 2026)
All-time low$0.1849 (Mar 19, 2025)
52-week high$0.3070
52-week low$0.2747
Median price$0.2837
Average price$0.2604
Largest weekly change+17.9% (Sep 17, 2025)
Weeks tracked89
Tracking sinceMar 12, 2025

Price History

1W

-2.6%

1M

-2.0%

3M

-7.5%

6M

-2.7%

1Y

-1.1%

3Y

N/A

5Y

N/A

All

+53.5%

Generic Alternatives

The matcher finds 8 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of AMITRIPTYLINE HCL 150 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for AMITRIPTYLINE HCL 150 MG TAB, manufactured by Advagen Pharma Ltd., is $0.2841 per EA (NDC 72888007201), effective Nov 18, 2026.

How has the price of AMITRIPTYLINE HCL 150 MG TAB changed over time?

Over the history we have for it, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has risen 53.5%. It has been tracked across 89 weekly CMS publications since Mar 12, 2025.

What are the highest and lowest recorded NADAC prices for AMITRIPTYLINE HCL 150 MG TAB?

Since Mar 12, 2025, the NADAC for AMITRIPTYLINE HCL 150 MG TAB has ranged from a low of $0.1849 (Mar 19, 2025) to a high of $0.3070 (Sep 16, 2026), with a median of $0.2837 per EA.

Are there cheaper alternatives to AMITRIPTYLINE HCL 150 MG TAB?

8 manufacturers publish a NADAC-priced product with the same active ingredient and strength as AMITRIPTYLINE HCL 150 MG TAB in a comparable dosage form, but none are currently priced below it.

Who manufactures AMITRIPTYLINE HCL 150 MG TAB?

AMITRIPTYLINE HCL 150 MG TAB (NDC 72888007201) is labeled by Advagen Pharma Ltd., and CMS classifies it as a generic product.